Passlogy Co Ltd
TSE:4426
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Passlogy Co Ltd
TSE:4426
|
JP |
|
Aichi Bank Ltd
TSE:8527
|
JP |
|
C
|
Cocorport Inc
TSE:9346
|
JP |
|
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
|
CN |
|
T
|
TIS Inc
TSE:3626
|
JP |
Income Statement
Earnings Waterfall
Passlogy Co Ltd
Income Statement
Passlogy Co Ltd
| Jun-2020 | Dec-2020 | Jun-2021 | Dec-2021 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ||||||||||||||||||||
| Interest Expense |
0
|
0
|
0
|
0
|
1
|
0
|
0
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
0
|
0
|
0
|
0
|
|
| Revenue |
426
N/A
|
458
+8%
|
400
-13%
|
401
+0%
|
408
+2%
|
495
+21%
|
368
-26%
|
457
+24%
|
355
-22%
|
358
+1%
|
359
+0%
|
361
+0%
|
359
-1%
|
357
0%
|
350
-2%
|
349
-1%
|
339
-3%
|
326
-4%
|
325
0%
|
|
| Gross Profit | ||||||||||||||||||||
| Cost of Revenue |
(75)
|
(89)
|
(103)
|
(114)
|
(114)
|
(139)
|
(101)
|
(130)
|
(106)
|
(110)
|
(109)
|
(108)
|
(111)
|
(116)
|
(123)
|
(127)
|
(126)
|
(122)
|
(130)
|
|
| Gross Profit |
352
N/A
|
369
+5%
|
297
-19%
|
287
-3%
|
295
+3%
|
356
+21%
|
267
-25%
|
327
+23%
|
249
-24%
|
248
0%
|
250
+1%
|
253
+1%
|
248
-2%
|
241
-3%
|
227
-6%
|
222
-2%
|
213
-4%
|
204
-4%
|
195
-4%
|
|
| Operating Income | ||||||||||||||||||||
| Operating Expenses |
(186)
|
(190)
|
(184)
|
(204)
|
(221)
|
(275)
|
(211)
|
(260)
|
(202)
|
(210)
|
(235)
|
(242)
|
(244)
|
(244)
|
(236)
|
(245)
|
(253)
|
(260)
|
(272)
|
|
| Selling, General & Administrative |
(185)
|
(190)
|
(177)
|
(204)
|
(210)
|
(272)
|
(209)
|
(258)
|
(195)
|
(210)
|
(235)
|
(242)
|
(242)
|
(244)
|
(236)
|
(245)
|
(249)
|
(260)
|
(272)
|
|
| Research & Development |
0
|
0
|
(6)
|
0
|
(9)
|
0
|
0
|
0
|
(5)
|
0
|
0
|
0
|
(1)
|
0
|
0
|
0
|
(3)
|
0
|
0
|
|
| Depreciation & Amortization |
(1)
|
0
|
(1)
|
0
|
(2)
|
0
|
0
|
0
|
(2)
|
0
|
0
|
0
|
(1)
|
0
|
0
|
0
|
(2)
|
0
|
0
|
|
| Other Operating Expenses |
(0)
|
0
|
(0)
|
(0)
|
0
|
(3)
|
(0)
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
0
|
|
| Operating Income |
165
N/A
|
179
+8%
|
114
-36%
|
84
-26%
|
74
-11%
|
81
+9%
|
55
-32%
|
67
+21%
|
47
-30%
|
38
-19%
|
15
-60%
|
11
-28%
|
4
-67%
|
(3)
N/A
|
(9)
-149%
|
(24)
-178%
|
(40)
-69%
|
(56)
-41%
|
(77)
-37%
|
|
| Pre-Tax Income | ||||||||||||||||||||
| Interest Income Expense |
(1)
|
(7)
|
9
|
37
|
38
|
38
|
35
|
35
|
35
|
47
|
27
|
27
|
79
|
53
|
129
|
129
|
86
|
86
|
74
|
|
| Non-Reccuring Items |
7
|
0
|
(0)
|
(1)
|
(3)
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Gain/Loss on Disposition of Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
4
|
0
|
0
|
0
|
5
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Other Income |
(0)
|
(0)
|
(1)
|
(1)
|
(0)
|
(0)
|
5
|
5
|
0
|
9
|
12
|
12
|
(0)
|
12
|
4
|
4
|
(0)
|
(0)
|
(0)
|
|
| Pre-Tax Income |
171
N/A
|
172
+1%
|
122
-29%
|
119
-3%
|
109
-8%
|
119
+9%
|
96
-19%
|
107
+12%
|
86
-20%
|
94
+10%
|
54
-43%
|
49
-8%
|
86
+75%
|
62
-28%
|
125
+101%
|
109
-12%
|
46
-58%
|
30
-36%
|
(3)
N/A
|
|
| Net Income | ||||||||||||||||||||
| Tax Provision |
(61)
|
(61)
|
(36)
|
(35)
|
(33)
|
(36)
|
(28)
|
(31)
|
(28)
|
(31)
|
(17)
|
(15)
|
(24)
|
(16)
|
(37)
|
(32)
|
(12)
|
(5)
|
5
|
|
| Income from Continuing Operations |
110
|
111
|
86
|
84
|
77
|
83
|
68
|
76
|
58
|
63
|
37
|
34
|
62
|
46
|
87
|
78
|
34
|
24
|
1
|
|
| Net Income (Common) |
110
N/A
|
111
+1%
|
86
-23%
|
84
-2%
|
77
-8%
|
83
+8%
|
68
-18%
|
76
+11%
|
58
-24%
|
63
+10%
|
37
-42%
|
34
-8%
|
62
+84%
|
46
-26%
|
87
+89%
|
78
-11%
|
34
-57%
|
24
-27%
|
1
-95%
|
|
| EPS (Diluted) |
55.16
N/A
|
55.48
+1%
|
42.83
-23%
|
41.79
-2%
|
38.39
-8%
|
41.46
+8%
|
34
-18%
|
37.81
+11%
|
28.77
-24%
|
31.66
+10%
|
18.41
-42%
|
16.95
-8%
|
31.23
+84%
|
23.1
-26%
|
43.77
+89%
|
38.91
-11%
|
16.81
-57%
|
12.23
-27%
|
0.68
-94%
|
|